Tag: Symptoms

Categories
Health

Lingering Covid signs pose ‘actually major problem,’ researcher says

German Covid cases rising 'exponentially' amid risky vaccine pause

A researcher studying so-called Covid long-distance drivers warned that persistent symptoms are a dire reality and can be a serious problem.

“We tracked approximately 60 different symptoms in this patient population,” said David Putrino, director of rehabilitation innovation at Mount Sinai Hospital in New York. “We really just need to focus on helping these patients and spreading awareness that this is indeed a really serious problem related to Covid.”

A new study from Northwestern University shows that 85% of long-distance drivers – Covid patients who have largely recovered from the worst illness but continue to have long-term symptoms – had four or more neurological symptoms. These symptoms include brain fog, headache, numbness or tingling, loss of taste and smell, and muscle pain.

Northwestern scientists call it the first study of its kind. It tracked 100 Covid patients, mostly women with an average age of 43 years.

Putrino told CNBC’s The News with Shepard Smith that the prevalence of long-term Covid is changing the way doctors treat patients, even with routine ailments.

“I think there were a lot of people before Covid who showed up with non-specific symptoms and they were concerned that they were being treated with formula medicine instead of being very patient-centered and symptom-centered in treatment approaches,” Putrino said. “One of the things doctors need to do now, when we see this increase in long-distance Covid activity, is listen to what patients are telling them.”

Categories
Health

Ivermectin Does Not Alleviate Delicate Covid-19 Signs, Research Finds

Ivermectin Does Not Alleviate Mild Covid-19 Symptoms, Study Finds

Ivermectin, a controversial anti-parasitic drug that has been touted as a potential Covid-19 treatment, doesn’t speed recovery in people with mild illnesses. This is the result of a randomized controlled trial published in the journal JAMA on Thursday.

Ivermectin is typically used to treat parasitic worms in both humans and animals, but the scientific evidence of its effectiveness against the coronavirus is thin. Some studies have shown that the drug can prevent several different viruses from replicating in cells. And last year, researchers in Australia found that high doses of ivermectin suppressed SARS-CoV-2, the virus that causes Covid-19, in cell cultures.

Such findings had driven the use of the drug against Covid-19, especially in Latin America.

“Ivermectin is currently used extensively,” said Dr. Eduardo López-Medina, doctor and researcher at the Center for Pediatric Infectious Diseases in Cali, Colombia, who led the new study. “In many countries in the Americas and other parts of the world, this is part of national guidelines for treating Covid.”

But the drug has also been shown to be divisive. While some scientists see potential, others suspect that effective inhibition of the coronavirus may require extremely high, potentially unsafe doses. Health officials have also feared that people desperate for coronavirus treatments might be taking versions of the drug formulated for pets. (It’s often used to prevent heartworms in dogs.)

“There have been many conflicting views on these, sometimes extremely conflicting views,” said Dr. Carlos Chaccour, a researcher at the Barcelona Institute for Global Health who was not involved in the new study. “I think it’s become another hydroxychloroquine.”

Updated

March 4, 2021, 9:28 p.m. ET

But neither the proponents nor the critics had much rigorous data to support their views. There are few well-controlled studies on the drug’s effectiveness against Covid-19, although more are expected in the coming months. The National Institutes of Health treatment guidelines indicate that there is insufficient evidence to recommend “for or against” the use of the drug in Covid-19 patients.

In the new study, Dr. López-Medina and his colleagues happened to add more than 400 people who had recently developed mild Covid-19 symptoms to receive five-day treatment with ivermectin or a placebo. They found that Covid-19 symptoms lasted an average of about 10 days in people who received the drug, compared to 12 days in those who received the placebo, a statistically insignificant difference.

The new study adds much-needed clinical data to the debate over the drug’s use to treat Covid-19, said Dr. Regina Rabinovich, a global health researcher at the TH Chan School of Public Health at Harvard who was not involved in the study.

However, she noted that the study was relatively small and didn’t answer the most pressing clinical question of whether ivermectin can prevent serious illness or death. “Duration of symptoms may not be the most important clinical or health parameter,” she said.

The researchers found that seven patients in the placebo group got worse after entering the study compared to four in the ivermectin group, but the numbers were too small to draw any meaningful conclusion.

“There was a little signal there and it would be interesting to see whether or not this signal we saw is real,” said Dr. López Medina. “But that would have to be answered in a larger process.”

Dr. López-Medina also pointed out that the study population was relatively young and healthy, with an average age of 37 and few underlying diseases that can make Covid-19 more dangerous.

Larger studies currently in progress could provide more definitive answers, said Dr. Rabinovich, who stated that she was “completely neutral” about the potential benefits of ivermectin. “I only want data because there is such a mess in the field.”

Categories
Health

Medical specialists attempt to set up ‘lengthy Covid’ analysis for sufferers with lasting signs

Medical experts try to establish 'long Covid' diagnosis for patients with lasting symptoms

Critical care carers insert an endotracheal tube into a patient with coronavirus disease (COVID-19) in the intensive care unit (ICU) at Sarasota Memorial Hospital in Sarasota, Florida on February 11, 2021.

Shannon Stapleton | Reuters

Some Covid-19 patients suffer from shortness of breath, fatigue, headaches and “brain fog” for months to almost a year after their first illness. Now global medical experts are working to better diagnose and treat what they tentatively refer to as “long covid”.

Earlier this week, the World Health Organization hosted a global meeting with “patients, clinicians and other stakeholders” to improve the agency’s understanding of the post-Covid medical condition, also known as Long Covid, WHO director general Tedros Adhanom Ghebreyesus said Friday.

The meeting was the first of many to come. The goal will ultimately be to produce an “agreed clinical description” of the disease so that doctors can diagnose and treat patients effectively, he said. Given the number of people infected with the virus worldwide – nearly 108 million people as of Friday – Tedros warned that many of these persistent symptoms are likely to appear.

“This disease affects patients with severe and mild Covid-19,” Tedros said during a press conference at the agency’s headquarters in Geneva. “Part of the challenge is that long-term Covid patients can have a range of different symptoms that can be persistent or come and go.”

Limited dates

So far, there have been a limited number of studies that will determine what symptoms are most common and how long they might last. The main focus was on people with a serious or fatal illness, not people who have recovered but still report persistent side effects, sometimes referred to as “long distance riders”.

Most Covid patients are believed to recover only weeks after their initial diagnosis, but some have symptoms for six months or even almost a year, medical experts say.

One of the largest global studies on Long Covid, published in early January, found that many people who have persistent illness after infection cannot work full-time six months later. The study, published on MedRxiv and not peer reviewed, interviewed more than 3,700 people, ages 18 to 80, from 56 countries to identify symptoms.

The most common symptoms after six months were fatigue, post-exercise fatigue, and cognitive dysfunction, sometimes called brain fog.

Is that unique to Covid-19?

“We really don’t know what is causing these symptoms. That is a focus of research right now,” said Dr. Allison Navis, a professor at the Icahn School of Medicine at Mount Sinai, during a call to the Infectious Diseases Society of America on Friday.

“The question that arises is whether this is something that is unique to Covid itself – and it is the Covid virus that is causing these symptoms – or whether this could be part of a general post-viral syndrome,” Navis said, adding, that medical experts see similar long-term symptoms after other viral infections.

Another study, published in the medical journal The Lancet in early January, looked at 1,733 patients discharged from a hospital in Wuhan, China, between January and May last year. Of these patients, 76% reported at least one symptom six months after their first illness. The proportion was higher among women.

“We found that fatigue or muscle weakness, sleep disorders, and anxiety or depression were common even 6 months after symptoms appeared,” the researchers wrote in the study.

They found that symptoms reported months after the Covid-19 diagnosis was consistent with data previously found in follow-up studies of Severe Acute Respiratory Syndrome (SARS), a coronavirus.

Post-Covid clinics are going online

Some large medical centers are currently setting up post-Covid clinics to care for patients with persistent symptoms. Navis said her clinic on Mount Sinai, New York treated a “fairly even” distribution of men and women with persistent illness, and the average age of patients was 40 years.

Dr. Kathleen Bell, a professor at the University of Texas’ Southwestern Medical Center, said her hospital’s long-term Covid-19 clinic began last April when a wave of infections hit Italy and New York at the start of the pandemic.

Bell said on the Infectious Diseases Society of America conference call on Friday that a number of professionals are required to staff the clinics because symptoms are uneven, including experts who can treat muscle weakness, heart-related disorders, and cognitive problems in the insane and health Problems after their diagnosis.

“It forces all of us, in many ways, to come together and make sure we have open lines of communication to address all of these issues for patients,” said Bell.

Bell added that the Centers for Disease Control and Prevention held a phone call in January with long Covid centers across the country to discuss their model for treating patients.

“I think the CDC is now trying to bring centers together and get some firmer guidelines on it, which is very exciting,” said Bell.

– CNBC’s Sam Meredith contributed to this report.

Categories
Business

Lengthy-haul Covid signs ought to be a ‘wake-up name’ for younger folks, Texas Youngsters’s physician says

Long-haul Covid symptoms should be a 'wake-up call' for young people, Texas Children's doctor says

Around 10 to 30% of all Covid patients suffer from long-distance symptoms. Sinais Center for Aftercare. These numbers should be a “wake up call” for young people and motivate them to avoid infection, said Dr. Peter Hotez of Texas Children’s Hospital on CNBC’s “The News with Shepard Smith”.

Patients with post-acute Covid syndrome typically suffer from severe fatigue, shortness of breath, digestive problems, “brain fog” and a racing heart. Some may even develop type 1 diabetes after contracting Covid, said Dr. Hotez. Endocrinologists are still trying to understand exactly why this is happening.

Another question that researchers still cannot answer is whether long-distance symptoms will remain in Covid patients for the rest of their lives. Millions of Americans are already infected, according to Hotez, and those who experienced mild symptoms and were able to stay home to recover are most likely to have problems with post-acute Covid syndrome later, according to later research.

Of all the lingering effects of Covid, Hotez said to Smith, “The ones that worry me most are the cognitive deficits. We call it ‘brain fog’ which makes it sound like it’s not that serious, but it is. You know people have it. ” terrible difficulty concentrating and that’s why it was so devastating because it’s difficult for people to get back to work. “

The post-acute Covid syndrome will have a significant impact on the economy and the health system, said Hotez. Covid has a “severe psychiatric burden”, even for people who were not infected. They can suffer from “post-traumatic stress” from losing a loved one, earning a living, or simply dealing with pandemic living conditions.

“As horrific as the deaths are and as heartbreaking as the deaths, this will be just one of many pieces of Covid-19 that will be with us. It’s also a wake-up call for young people,” Hotez said.

Categories
Health

Small Variety of Covid Sufferers Develop Extreme Psychotic Signs

Small Number of Covid Patients Develop Severe Psychotic Symptoms

Brain scans, spinal fluid analyzes, and other tests did not reveal any brain infection, said Dr. Gabbay, whose hospital has treated two patients with postcovid psychosis: a 49-year-old man who heard voices believing he was the devil and a 34-year-old woman who started carrying a knife, undressing in front of strangers, and putting in hand sanitizer to give her food.

According to reports, most of these patients did not get very sick from Covid-19. The patients Dr. Goueli did not have any breathing problems, but they had subtle neurological symptoms such as hand tingling, dizziness, headache, or decreased odor. Then, two weeks to a few months later, they develop “this profound psychosis that is really dangerous and scary for everyone around them”.

It is also noticeable that most of the patients were between 30, 40 and 50 years old. “It is very rare for you to develop this type of psychosis in this age group,” said Dr. Goueli, since such symptoms are more likely to be associated with schizophrenia in young people or dementia in older people. And some patients – like the physiotherapist who took herself to the hospital – understood that something was wrong, while “people with psychosis usually don’t know that they have lost touch with reality”.

Some post-Covid patients who developed psychosis had to be hospitalized for weeks, where doctors tried different drugs before they found one that worked.

Dr. Robert Yolken, a neurovirology expert at the Johns Hopkins University Medical School in Baltimore, said that while people can physically recover from Covid-19, in some cases their immune systems may not be able to turn off or due to “Delayed elimination of a small amount of virus. “

Persistent immune activation is also one of the main explanations for brain fog and memory problems that plague many Covid survivors, and Emily Severance, a schizophrenia expert at Johns Hopkins, said that post-Covid cognitive and psychiatric effects may be due to “something similar in the brain “Are due.

Categories
World News

French President Macron, Freed from Covid Signs, Leaves Isolation

French President Macron, Free of Covid Symptoms, Leaves Isolation

PARIS – A week after testing positive for the coronavirus for the first time, French President Emmanuel Macron stopped isolating because he was no longer showing symptoms, shared a statement from the Élysée Palace, its official office, on Thursday With.

During his quarantine, Mr Macron – who had typical symptoms of Covid-19 such as fatigue, cough and pain – was “able to remain mobilized in the most important current affairs of our country and hold meetings and councils as planned” statement read.

Mr Macron contracted the virus at a time when a surge in infections across France was shedding hopes that people could safely celebrate the end of the year celebrations.

French health protocols recommend an isolation period of seven days after symptoms appear or a positive virus test. However, a negative test is not required to leave the isolation after this time has elapsed.

The French president was not the first world leader to contract the virus. But unlike several other prominent leaders who have had it – including President Trump, President Jair Bolsonaro of Brazil and Prime Minister Boris Johnson of the UK – Mr Macron has consistently emphasized the threat posed by the virus.

Although it is still unclear how Mr Macron got infected, last week’s announcement that he had the disease prompted a cascade of leaders who had met with him over the past few days to isolate himself, including the Spanish one Prime Minister Pedro Sánchez. Prime Minister António Costa of Portugal; and the President of the European Council, Charles Michel.

French Health Minister Olivier Véran said Mr Macron may have been infected at the December 10-11 European Council meetings. Slovak Prime Minister Igor Matovic, who attended the same gatherings, also tested positive for the virus.

Mr Macron, who celebrated his 43rd birthday in isolation on December 21, used his quarantine period to reiterate warnings about the risk of contamination.

In Thursday’s statement announcing his improvement, he urged members of the French public to limit their contacts and remain vigilant during the Christmas holidays by “ventilating rooms, wearing a mask and washing their hands regularly”.

Over the past week, daily updates on Mr Macron’s health have been released by Mr Macron himself, by his personal doctor or through official statements from the Élysée Palace – a departure from France’s tradition of secrecy regarding the health of its presidents.

In a self-recorded video of his presidential retreat near Versailles last week, a tired-looking Mr. Macron said he was suffering from a cough, headache and fatigue. His office reported the first signs of improvement on Wednesday after describing his health as “stable” for the past few days.

Mr. Macron held several virtual meetings with his ministers and continued exchanges with foreign leaders such as Russian President Vladimir V. Putin on Tuesday.

In an interview with French magazine L’Express on December 17, the day it tested positive and published on Tuesday, Mr Macron said he wanted to rely on “patriotic and European” French people to undermine an “undermined” one “Land” to reconcile “” divisions “that persist three and a half years after his tenure as President.

With more than 60,000 deaths caused by the coronavirus and around 2.5 million reported coronavirus infections, France has taken a heavy toll on the pandemic. While the number of new infections had dropped below 10,000 per day by the end of November, they have dropped to an average of 14,000 new cases per day over the past seven days, shedding hope that the second wave is over.

On Thursday, the French health authority approved the Pfizer BioNTech vaccine, which officially opened the way for vaccination after receiving support from the European Union earlier this week.

The vaccination campaign in France begins on Sunday in several retirement homes and care facilities. The French authorities have ordered around 200 million doses and established a three-phase vaccination strategy, starting with the elderly and at-risk nursing home workers.